Promoter region polymorphism in the human TNF-α gene is not associated with lichen sclerosus

Experimental Dermatology

Volumn 5, Issue 4, 1996, Pages 227-229

  Clay, F E ^a   Cork, M J ^a   Wilson, A G ^a   Crane, A M ^a   Lewis, F ^a   Harrington, C I ^a   Duff, G W ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cytokine; Inflammatory skin disease; Major histocompatibility complex

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PROMOTER REGION;

EID: 0029834794     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1996.tb00121.x     Document Type: Article

References (20)

1. Ridley CM. Lichen sclerosus: a review. Eur J Dermatol 1994: 4: 99-105.
2. Friedrich Jr KG, MacLaren NK. Genetic aspects of vulvar lichen sclerosus. Am J Obs Gyn 1984: 150:161-166.
3. Meyrick-Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus and atrophicus and autoimmunity, a study of 350 women. Br J Dermatol 1988: 118: 41-46.
4. Harrington CI, Dunsmore IR. An investigation into the incidence of autoimmune disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol 1981: 104: 563.
5. Meyrick-Thomas RH, Ridley CM, Sherwood F, Black MM. The lack of association of lichen sclerosus and atrophicus with HLA-A and B tissue antigens. Clin Exp Dermatol 1984: 9: 290-292.
6. Purcell KG, Spencer LV, Simpson PM, Helman SW, Oldfather JW, Fowler Jr JF. HLA antigens in lichen sclerosus and atrophicus. Arch Dermatol 1990: 17s: 1043-1045.
7. Marren P, Yell J, Poskitt L, Welsh K, Wojnarowska F. The immunogenetic basis for lichen sclerosus. Br J Dermatol 1993: 129: 23 (abstr).
8. Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995: 132: 197-203.
9. Beutler B, Cerami A. The biology of cachectin/FNF - a primary mediator of the host response. Ann Rev Immunol 1989: 7: 625-655.
10. Carroll MC, Katzman P, Alicot EM et al. Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. Proc Natl Acad Sci USA 1987: 84: 8535-8539.
11. Sariban E, Imamura K, Leubbers R. Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 1988: 81: 1506-1510.
12. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990: 171: 465-475.
13. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II associated differences in production of tumour necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990: 87: 1233-1237.
14. Molvig J, Baek L, Christensen P et al. Endotoxin stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha and prostaglandin E2 show stable inter-individual differences. Scand J Immunol 1988: 27: 705-716.
15. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW Single base polymorphism in the human tumour necrosis factor alpha (TNFα) gene detectable by Ncol restriction of PCR product. Hu Mol Genet 1992: 1: 353.
16. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor α promoter region is strongley associated with HLA A1, B8, and DR3 alleles. J Exp Med 1992: 177: 557-560.
17. Vaughan V. PCR-SSO typing for HLA-DRB alleles. Eur J Immunogenetics 1991: 18: 69-80.
18. Jacob CO. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Immunol Today 1992: 13: 122-125.
19. Clay FE, Cork MJ, Tarlow JK, Blakemore AIF, Harrington CI, Lewis F, Duff GW. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Human Genetics 1994: 94: 407-410.
20. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 1994: 37: 1380-1385.